Stock M12 M1 KLINIKEN AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings M1 Kliniken AG

Equities

M12

DE000A0STSQ8

Market Closed - Xetra
Other stock markets
 11:36:10 2024-04-26 am EDT 		5-day change 1st Jan Change
13.3 EUR +5.56% Intraday chart for M1 Kliniken AG -4.32% +18.75%
Feb. 05 M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares MT
2023 M1 Kliniken Takes Ownership of Dutch Online Pharmacy MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • With regards to fundamentals, the enterprise value to sales ratio is at 0.74 for the current period. Therefore, the company is undervalued.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • With an expected P/E ratio at 33.25 and 25.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company appears highly valued given the size of its balance sheet.
  • The company is highly valued given the cash flows generated by its activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
M1 KLINIKEN AG Stock M1 Kliniken AG
+18.75% 260M -
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
B+
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
B+
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
B+
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-0.10% 7.68B
A-
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+18.43% 7.2B
D
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
B-
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B -
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. M12 Stock
  4. Ratings M1 Kliniken AG